Peiffer, Lukas
Farahpour, Farnoush
Sriram, Ashwin
Spassova, Ivelina
Hoffmann, Daniel
Kubat, Linda
Stoitzner, Patrizia
Gambichler, Thilo
Sucker, Antje
Ugurel, Selma
Schadendorf, Dirk
Becker, Jürgen C. http://orcid.org/0000-0001-9183-653X
Funding for this research was provided by:
Deutsches Konsortium für Translationale Krebsforschung (ED03)
Deutsches Krebsforschungszentrum (DKFZ)
Article History
Received: 5 May 2020
Accepted: 16 November 2020
First Online: 4 December 2020
Compliance with ethical standards
:
: T. Gambichler has received speakers and/or advisory board honoraria from BMS, Sanofi-Genzyme, MSD, Novartis Pharma, Roche, Abbvie, Almirall, Janssen, Lilly, Pfizer, Pierre Fabre, outside the submitted work. Selma Ugurel declares research support from Bristol Myers Squibb and Merck Serono; speakers and advisory board honoraria from Bristol Myers Squibb, Merck Sharp and Dohme, Merck Serono, Novartis and Roche, as well as travel support from Bristol Myers Squibb, Merck Sharp and Dohme. Dirk Schadendorf has received honoraria from Bristol-Myers Squibb, Roche, Novartis, Regeneron, Sanofi, MerckSerono, Amgen, 4SC, Merck Sharp and Dohme, Array, Pierre Fabre, Philogen, Incyte, and Pfizer, and research funding from Bristol-Myers Squibb and Novartis. Jürgen C. Becker has received speaker honoraria from Amgen, MerckSerono, Pfizer, and Sanofi; advisory board honoraria from 4SC, Amgen, CureVac, eTheRNA, MerckSerono, Novartis and InProTher, as well as research funding from Alcedis, Boehringer Ingelheim, Bristol-Myers Squibb, IQVIA, and MerckSerono; he also received travel support from 4SC and Incyte. All other authors state no conflict of interest.
: The project was approved by the ethics committee of the University Duisburg-Essen (11-4715; 17-7538-BO) and was conducted in accordance with the Declaration of Helsinki. Written consent from each patient was obtained prior to any measures.